Treatment of Scleroderma-Interstitial Lung Disease With Cyclophosphamide Is Associated With Less Progressive Fibrosis on Serial Thoracic High-Resolution CT Scan Than Placebo: Findings From the Scleroderma Lung Study

BACKGROUND: The Scleroderma Lung Study (SLS) demonstrated significant treatment-associated improvements in pulmonary function and symptoms when patients with scleroderma-related interstitial lung disease (SSc-ILD) were treated with a 1-year course of cyclophosphamide (CYC) in a randomized, double-bl...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Goldin, Jonathan, Elashoff, Robert, Kim, Hyun J., Yan, Xaiohong, Lynch, David, Strollo, Diane, Roth, Michael D., Clements, Philip, Furst, Daniel E., Khanna, Dinesh, Vasunilashorn, Srainnapha, Li, Gang, Tashkin, Donald P.
Formato: Artigo
Idioma:Inglês
Publicado: American College of Chest Physicians 2009
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2773360/
https://ncbi.nlm.nih.gov/pubmed/19892673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.09-0108
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares